Teladoc Health Inc (TDOC) CEO Jason N. Gorevic Sells 25,000 Shares

Share on StockTwits

Teladoc Health Inc (NYSE:TDOC) CEO Jason N. Gorevic sold 25,000 shares of the firm’s stock in a transaction that occurred on Monday, September 17th. The stock was sold at an average price of $75.05, for a total value of $1,876,250.00. Following the transaction, the chief executive officer now owns 536,184 shares of the company’s stock, valued at approximately $40,240,609.20. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

NYSE TDOC traded up $3.51 during trading on Friday, reaching $65.94. 2,619,045 shares of the company’s stock were exchanged, compared to its average volume of 1,270,685. The company has a market cap of $6.01 billion, a PE ratio of -39.96 and a beta of 0.57. The company has a quick ratio of 3.14, a current ratio of 3.14 and a debt-to-equity ratio of 0.58. Teladoc Health Inc has a fifty-two week low of $27.30 and a fifty-two week high of $89.05.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, August 1st. The health services provider reported ($0.37) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.38) by $0.01. The firm had revenue of $94.60 million for the quarter, compared to the consensus estimate of $91.56 million. Teladoc Health had a negative return on equity of 19.10% and a negative net margin of 37.78%. The business’s revenue was up 112.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.28) earnings per share. As a group, research analysts anticipate that Teladoc Health Inc will post -1.51 EPS for the current fiscal year.

A number of research firms recently weighed in on TDOC. SunTrust Banks raised their price target on Teladoc Health to $100.00 and gave the company a “buy” rating in a report on Monday, September 24th. KeyCorp lifted their target price on Teladoc Health from $90.00 to $94.00 and gave the company an “overweight” rating in a research note on Friday, September 28th. Oppenheimer raised their price target on Teladoc Health from $68.00 to $89.00 and gave the stock an “outperform” rating in a research report on Friday, September 28th. Citigroup raised their price target on Teladoc Health from $80.00 to $88.00 and gave the stock a “buy” rating in a research report on Friday, September 21st. Finally, Piper Jaffray Companies raised their price target on Teladoc Health to $84.00 and gave the stock an “overweight” rating in a research report on Friday, September 21st. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $79.79.

Several institutional investors have recently bought and sold shares of TDOC. Bank of America Corp DE boosted its stake in shares of Teladoc Health by 82.8% in the second quarter. Bank of America Corp DE now owns 1,883,185 shares of the health services provider’s stock valued at $109,318,000 after buying an additional 853,076 shares during the period. Summit Partners L P bought a new stake in shares of Teladoc Health in the second quarter valued at approximately $37,772,000. Westwood Management Corp IL boosted its stake in shares of Teladoc Health by 1,342.6% in the second quarter. Westwood Management Corp IL now owns 585,700 shares of the health services provider’s stock valued at $34,000,000 after buying an additional 545,100 shares during the period. Bellevue Group AG boosted its stake in shares of Teladoc Health by 997.2% in the first quarter. Bellevue Group AG now owns 515,694 shares of the health services provider’s stock valued at $20,782,000 after buying an additional 468,694 shares during the period. Finally, BlackRock Inc. boosted its stake in shares of Teladoc Health by 9.0% in the second quarter. BlackRock Inc. now owns 5,318,850 shares of the health services provider’s stock valued at $308,759,000 after buying an additional 437,136 shares during the period.

About Teladoc Health

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Further Reading: Price to Earnings Ratio (PE) Basics

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply